Alessandro Grillo is a research scientist in Promidis, part of the IRBM Group. His work is focused on the identification of innovative drugs in high unmet medical-need areas, and his work is a contribution to the medicinal chemistry department. In 2012, he earned a degree in medicinal chemistry at the University of Siena, and then he obtained his PhD degree in Chemical and Pharmaceutical Sciences in 2016, at the same University. Then he spent a period as a postdoctoral fellow at the Purdue University in West Lafayette (IN), USA, in the Department of Chemistry and Medicinal Chemistry, under the supervision of Professor Arun K. Ghosh. His research activity focuses on the development of bioactive compounds, with a special emphasis on CNS disease and antitumor and antiviral agents.